Functional Equivalency of Created and Natural Wetlands in the Central Appalachians: Reproductive Success, Call Phenology, and Diet Composition of Amphibians

Evaluating the adequacy of created wetlands to replace the functions of lost natural wetlands is important because wetland mitigation is a major tool used to offset wetland losses. However, measurements such as vegetative cover and presence of wildlife may not provide sufficient evidence that created wetlands are functioning properly and thus examining the ecology of wetland biota such as that of amphibians may be a more useful surrogate for function. The objectives of this study were to assess the reproductive success, temporal calling patterns, and diet composition of amphibians inhabiting created wetlands relative to natural wetlands in order to facilitate determination of the adequacy of created wetlands as functional replacements of natural wetlands.;To evaluate reproductive success, I compared the abundance of amphibian metamorphs and survival and growth of larval amphibians in created wetlands relative to natural wetlands. Amphibian metamorphs were trapped in created and natural wetlands during the spring and summer of 2009 and 2010, and 165 green frog (Lithobates clamitans) larvae were raised during the spring of 2010 in laboratory aquaria containing water from created or natural wetlands. Abundance of spring peeper (Pseudacris crucifer ) metamorphs decreased significantly from 2009 to 2010 and abundance of green frog metamorphs increased with habitat complexity, but both were unaffected by wetland type. Detection probability of metamorphs of both species was very low, increased with water temperature, and declined with month of observation. Survival, growth curves, and mass were similar between green frog larvae raised in created and natural wetland aquaria. My results suggest that the function of providing adequate breeding habitat for generalist amphibians such as green frogs and spring peepers is being fulfilled by the created wetlands that were examined.;I compared the occupancy and detection of calling anurans in created wetlands relative to natural wetlands to assess temporal calling patterns. Five-minute, ten-minute, and broadcast call surveys were performed at 24 wetlands throughout the Central Appalachians once every month from March through August of 2009 and 2010. Occupancy modeling was used to estimate the occupancy and detection of individual species, incorporating relevant environmental variables. The occupancy of anurans did not differ between created and natural wetlands. Detection of anurans was largely unaffected by call survey type, but several environmental covariates had a significant effect on the detectability of calling anurans. I conclude that the function of providing adequate breeding habitat for adult anurans is being fulfilled by the created wetlands that were examined.;To assess the diet composition of amphibians, I measured the diet composition of adult red-spotted newts (Notophthalmus viridescens viridescens ) and compared the selection of prey by newts between created and natural wetlands. Newts were trapped during the spring and summer of 2009 and 2010, and the stomach contents of 149 newts were obtained with gastric lavage. Invertebrate prey availability was obtained within a 5 m radius of each captured newt. Selection of prey by newts was nonrandom, but was only minimally affected by wetland type. Both dietary breadth and prey selection were affected primarily by time of year, likely driven by temporal variation in invertebrate abundance. My results suggest that the function of providing an adequate prey base for a generalist wetland predator such as the red-spotted newt is being fulfilled for the created wetlands that were examined

Magnitude Judgements Are Influenced by the Relative Positions of Data Points Within Axis Limits

When visualising data, chart designers have the freedom to choose the upper and lower limits of numerical axes. Axis limits can determine the physical characteristics of plotted values, such as the physical position of data points in dot plots. In two experiments (total N=300), we demonstrate that axis limits affect viewers' interpretations of the magnitudes of plotted values. Participants did not simply associate values presented at higher vertical positions with greater magnitudes. Instead, participants considered the relative positions of data points within the axis limits. Data points were considered to represent larger values when they were closer to the end of the axis associated with greater values, even when they were presented at the bottom of a chart. This provides further evidence of framing effects in the display of data, and offers insight into the cognitive mechanisms involved in assessing magnitude in data visualisations

Thinking on Your Feet: Enhancing Foveated Rendering in Virtual Reality During User Activity

As prices fall, VR technology is experiencing renewed levels of consumer interest. Despite wider access, VR still requires levels of computational ability and bandwidth that often cannot be achieved with consumer-grade equipment. Foveated rendering represents one of the most promising methods for the optimization of VR content while keeping the quality of the user’s experience intact. The user’s ability to explore and move through the environment with 6DOF separates VR from traditional display technologies. In this work, we explore if the type of movement (Active versus Implied) and attentional task type (Simple Fixations versus Fixation, Discrimination, and Counting) affect the extent to which a dynamic foveated rendering method using Variable Rate Shading (VRS) optimizes a VR scene. Using psychophysics methods we conduct user studies and recover the Maximum Tolerated Diameter (MTD) at which users fail to notice drops in quality. We find that during self-movement, performing a task that requires more attention masks severe shading reductions and that only 31.7% of the headset’s FOV is required to be rendered at the native pixel sampling rate

Altered spring phenology of North American freshwater turtles and the importance of representative populations

Globally, populations of diverse taxa have altered phenology in response to climate change. However, most research has focused on a single population of a given taxon, which may be unrepresentative for comparative analyses, and few long‐term studies of phenology in ectothermic amniotes have been published. We test for climate‐altered phenology using long‐term studies (10–36 years) of nesting behavior in 14 populations representing six genera of freshwater turtles (Chelydra, Chrysemys, Kinosternon,Malaclemys, Sternotherus, and Trachemys). Nesting season initiation occurs earlier in more recent years, with 11 of the populations advancing phenology. The onset of nesting for nearly all populations correlated well with temperatures during the month preceding nesting. Still, certain populations of some species have not advanced phenology as might be expected from global patterns of climate change. This collection of findings suggests a proximate link between local climate and reproduction that is potentially caused by variation in spring emergence from hibernation, ability to process food, and thermoregulatory opportunities prior to nesting. However, even though all species had populations with at least some evidence of phenological advancement, geographic variation in phenology within and among turtle species underscores the critical importance of representative data for accurate comprehensive assessments of the biotic impacts of climate change

Altered spring phenology of North American freshwater turtles and the importance of representative populations

Globally, populations of diverse taxa have altered phenology in response to climate change. However, most research has focused on a single population of a given taxon, which may be unrepresentative for comparative analyses, and few long-term studies of phenology in ectothermic amniotes have been published. We test for climate- altered phenology using long-term studies (10–36 years) of nesting behavior in 14 populations representing six genera of freshwater turtles (Chelydra, Chrysemys, Kinosternon, Malaclemys, Sternotherus, and Trachemys). Nesting season initiation oc- curs earlier in more recent years, with 11 of the populations advancing phenology. The onset of nesting for nearly all populations correlated well with temperatures during the month preceding nesting. Still, certain populations of some species have not advanced phenology as might be expected from global patterns of climate change. This collection of findings suggests a proximate link between local climate and reproduction that is potentially caused by variation in spring emergence from hibernation, ability to process food, and thermoregulatory opportunities prior to nesting. However, even though all species had populations with at least some evi- dence of phenological advancement, geographic variation in phenology within and among turtle species underscores the critical importance of representative data for accurate comprehensive assessments of the biotic impacts of climate change

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

Background: Experimental and clinical data suggest that reducing inflammation without affecting lipid levels may reduce the risk of cardiovascular disease. Yet, the inflammatory hypothesis of atherothrombosis has remained unproved. Methods: We conducted a randomized, double-blind trial of canakinumab, a therapeutic monoclonal antibody targeting interleukin-1β, involving 10,061 patients with previous myocardial infarction and a high-sensitivity C-reactive protein level of 2 mg or more per liter. The trial compared three doses of canakinumab (50 mg, 150 mg, and 300 mg, administered subcutaneously every 3 months) with placebo. The primary efficacy end point was nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. RESULTS: At 48 months, the median reduction from baseline in the high-sensitivity C-reactive protein level was 26 percentage points greater in the group that received the 50-mg dose of canakinumab, 37 percentage points greater in the 150-mg group, and 41 percentage points greater in the 300-mg group than in the placebo group. Canakinumab did not reduce lipid levels from baseline. At a median follow-up of 3.7 years, the incidence rate for the primary end point was 4.50 events per 100 person-years in the placebo group, 4.11 events per 100 person-years in the 50-mg group, 3.86 events per 100 person-years in the 150-mg group, and 3.90 events per 100 person-years in the 300-mg group. The hazard ratios as compared with placebo were as follows: in the 50-mg group, 0.93 (95% confidence interval [CI], 0.80 to 1.07; P = 0.30); in the 150-mg group, 0.85 (95% CI, 0.74 to 0.98; P = 0.021); and in the 300-mg group, 0.86 (95% CI, 0.75 to 0.99; P = 0.031). The 150-mg dose, but not the other doses, met the prespecified multiplicity-adjusted threshold for statistical significance for the primary end point and the secondary end point that additionally included hospitalization for unstable angina that led to urgent revascularization (hazard ratio vs. placebo, 0.83; 95% CI, 0.73 to 0.95; P = 0.005). Canakinumab was associated with a higher incidence of fatal infection than was placebo. There was no significant difference in all-cause mortality (hazard ratio for all canakinumab doses vs. placebo, 0.94; 95% CI, 0.83 to 1.06; P = 0.31). Conclusions: Antiinflammatory therapy targeting the interleukin-1β innate immunity pathway with canakinumab at a dose of 150 mg every 3 months led to a significantly lower rate of recurrent cardiovascular events than placebo, independent of lipid-level lowering. (Funded by Novartis; CANTOS ClinicalTrials.gov number, NCT01327846.

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention